Korro Bio, Inc. (KRRO) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Korro Bio, Inc. in 2026. The next earnings report is expected on November 18, 2026.
Next earnings date
18 Nov 2026
In 90 days
EPS estimate
-1.26
Revenue estimate
166.7K
Past earnings
Latest earnings analysis
Korro Bio, Inc. beat consensus expectations for EPS but missed on revenue in the latest quarter, with EPS of -$1.07 versus an expected -$1.338 and revenue of $0, falling 100.0% short of estimates. In the prior quarter EPS also came in ahead of expectations while revenue missed estimates as well.
No dividend history available.
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Korro Bio, Inc. (KRRO) is scheduled to report earnings on November 18, 2026.
Korro Bio, Inc. (KRRO) last reported earnings on August 6, 2026.
Korro Bio, Inc. (KRRO) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.